Biggest changeThe following tables reconcile the Company’s non-GAAP financial measures (unaudited) to their most directly comparable GAAP financial measures (dollars in thousands, unless otherwise noted, except per share amounts): Non-GAAP Operating Income and Margin Reconciliations For the years ended December 31, 2024 2023 2022 Operating income $ 194,706 $ 214,495 $ 52,304 Acquisition-related expenses (a) 1,854 — 8,812 Restructuring and related charges, net (b) 6,530 7,588 3,163 Strategic planning (credits) expenses (c) (290) 4,704 14,446 Executive transition costs (d) 7,288 688 2,813 Customer insolvency costs (e) 3,213 — — Impairment charges (k) — — 93,000 Russia-Ukraine conflict related expenses (l) — — 2,487 Other charges (n) 399 299 866 Non-GAAP operating income $ 213,700 $ 227,774 $ 177,891 Non-GAAP operating margin (%) (r) 11.6 % 11.7 % 9.2 % 31 EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income Reconciliations For the years ended December 31, 2024 2023 2022 Net income (loss) attributable to Quaker Chemical Corporation $ 116,644 $ 112,748 $ (15,931) Depreciation and amortization (p) 85,108 83,020 81,514 Interest expense, net 41,002 50,699 32,579 Taxes on income (loss) before equity in net income of associated companies (q) 49,300 55,585 24,925 EBITDA 292,054 302,052 123,087 Equity (income) loss in a captive insurance company (h) (2,930) (2,090) 1,427 Acquisition-related expenses (credits) (a) 1,454 (475) 10,990 Restructuring and related charges, net (b) 6,530 7,588 3,163 Strategic planning (credits) expenses (c) (290) 4,704 14,446 Executive transition costs (d) 7,288 688 2,813 Customer insolvency costs (e) 3,213 — — Facility remediation recoveries, net (f) — (2,141) (1,804) Product liability claim costs, net (g) 2,040 — — Business interruption insurance proceeds (i) (1,000) — — Currency conversion impacts of hyper-inflationary economies (j) 811 7,849 1,617 Impairment charges (k) — — 93,000 Russia-Ukraine conflict related expenses (l) — — 2,487 Loss on extinguishment of debt (m) — — 6,763 Other charges (credits) (n) 1,748 2,204 (839) Adjusted EBITDA $ 310,918 $ 320,379 $ 257,150 Adjusted EBITDA margin (%) (r) 16.9 % 16.4 % 13.2 % Adjusted EBITDA $ 310,918 $ 320,379 $ 257,150 Less: Depreciation and amortization - adjusted (p) 85,108 83,020 81,514 Less: Interest expense, net 41,002 50,699 32,579 Less: Taxes on income (loss) before equity in net income of associated companies - adjusted (o)(q) 51,352 49,017 37,737 Non-GAAP net income $ 133,456 $ 137,643 $ 105,320 32 Non-GAAP Earnings per Diluted Share Reconciliations For the years ending December 31, 2024 2023 2022 GAAP earnings (loss) per diluted share attributable to Quaker Chemical Corporation common shareholders $ 6.51 $ 6.26 $ (0.89) Equity (income) loss in a captive insurance company per diluted share (h) (0.16) (0.12) 0.08 Acquisition-related expenses (credits) per diluted share (a) 0.06 (0.03) 0.49 Restructuring and related charges, net per diluted share (b) 0.28 0.32 0.13 Strategic planning (credits) expenses per diluted share (c) (0.01) 0.21 0.63 Executive transition costs per diluted share (d) 0.31 0.03 0.12 Customer insolvency costs per diluted share (e) 0.13 — — Facility remediation recoveries, net per diluted share (f) — (0.09) (0.08) Product liability claim costs, net per diluted share (g) 0.09 — — Business interruption insurance proceeds per diluted share (i) (0.04) — — Currency conversion impacts of hyper-inflationary economies per diluted share (j) 0.05 0.44 0.09 Impairment charges per diluted share (k) — — 5.19 Russia-Ukraine conflict related expenses per diluted share (l) — — 0.12 Loss on extinguishment of debt per diluted share (m) — — 0.29 Other charges (credits) per diluted share (n) 0.05 0.09 (0.04) Impact of certain discrete tax items per diluted share (o) 0.17 0.54 (0.26) Non-GAAP earnings per diluted share (s) $ 7.44 $ 7.65 $ 5.87 (a) Acquisition-related expenses (credits) include expense associated with the Company's recent and potential acquisitions, including legal, financial, consulting and other costs.
Biggest changeThe following tables reconcile the Company’s non-GAAP financial measures (unaudited) to their most directly comparable GAAP financial measures (dollars in thousands, unless otherwise noted, except per share amounts): Non-GAAP Gross Profit and Margin Reconciliations For the years ended December 31, 2025 2024 2023 Gross profit $ 679,372 $ 686,030 $ 705,644 Acquisition-related step-up inventory amortization (a) 6,022 — — Gain on inventory and other adjustments (o) (2,933) — — Non-GAAP gross profit $ 682,461 $ 686,030 $ 705,644 Non-GAAP gross margin (%) (u) 36.1 % 37.3 % 36.1 % Non-GAAP Operating Income and Margin Reconciliations For the years ended December 31, 2025 2024 2023 Operating income $ 52,986 $ 194,706 $ 214,495 Acquisition-related step-up inventory amortization (a) 6,022 — — Restructuring and related charges, net (b) 35,130 6,530 7,588 Acquisition-related expenses (credits) (c) 12,031 1,854 — Strategic planning expenses (credits) (d) 579 (290) 4,704 Executive transition costs (f) — 7,288 688 Customer insolvency costs (g) — 3,213 — Gain on inventory and other adjustments (o) (3,256) — — Impairment charges (i) 88,840 — — Acquisition-related depreciation and amortization (j) 4,975 — — Other charges (credits) (p) 2,098 399 299 Non-GAAP operating income $ 199,405 $ 213,700 $ 227,774 Non-GAAP operating margin (%) (u) 10.6 % 11.6 % 11.7 % 33 EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income Reconciliations For the years ended December 31, 2025 2024 2023 Net income attributable to Quaker Chemical Corporation $ (2,488) $ 116,644 $ 112,748 Depreciation and amortization (s) 94,402 85,108 83,020 Interest expense 44,048 41,002 50,699 Taxes on income before equity in net income of associated companies (t) 24,607 49,300 55,585 EBITDA 160,569 292,054 302,052 Equity income in a captive insurance company (q) (4,272) (2,930) (2,090) Acquisition-related step-up inventory amortization (a) 6,022 — — Restructuring and related charges, net (b) 35,130 6,530 7,588 Acquisition-related expenses (credits) (c) 12,031 1,454 (475) Strategic planning expenses (credits) (d) 579 (290) 4,704 Gain on inventory and other adjustments (o) (3,256) — — Pension and postretirement benefit costs, non-service components (e) 1,676 1,827 2,033 Executive transition costs (f) — 7,288 688 Customer insolvency costs (g) — 3,213 — Currency conversion impacts of hyper-inflationary economies (h) 2,216 811 7,849 Impairment charges (i) 88,840 — — Loss on acquisition-related hedges (k) 1,351 — — Gain on sale of assets (l) (2,534) (492) — Multiemployer plan withdrawal charge (m) 923 — — Brazilian non-income tax credits (n) (1,762) — — Other charges (credits) (p) 1,725 1,453 (1,970) Adjusted EBITDA $ 299,238 $ 310,918 $ 320,379 Adjusted EBITDA margin (%) (u) 15.8 % 16.9 % 16.4 % Adjusted EBITDA $ 299,238 $ 310,918 $ 320,379 Less: Depreciation and amortization - adjusted (s) 94,402 85,108 83,020 Less: Interest expense 44,048 41,002 50,699 Less: Taxes on income (loss) before equity in net income of associated companies - adjusted (r)(t) 42,608 51,352 49,017 Plus: Acquisition-related depreciation and amortization (j) 4,975 — — Non-GAAP net income $ 123,155 $ 133,456 $ 137,643 34 Non-GAAP Earnings per Diluted Share Reconciliations For the years ending December 31, 2025 2024 2023 GAAP earnings per diluted share attributable to Quaker Chemical Corporation common shareholders $ (0.14) $ 6.51 $ 6.26 Equity income in a captive insurance company (q) (0.24) (0.16) (0.12) Acquisition-related step-up inventory amortization (a) 0.25 — — Restructuring and related charges, net (b) 1.49 0.28 0.32 Acquisition-related expenses (credits) (c) 0.53 0.06 (0.03) Strategic planning expenses (credits) (d) 0.03 (0.01) 0.21 Pension and postretirement benefit costs, non-service components (e) 0.07 0.05 0.09 Executive transition costs (f) — 0.31 0.03 Customer insolvency costs (g) — 0.13 — Currency conversion impacts of hyper-inflationary economies (h) 0.13 0.05 0.44 Impairment charges (i) 4.91 — — Acquisition-related depreciation and amortization (j) 0.20 — — Loss on acquisition-related hedges (k) 0.06 — — Gain on sale of assets (l) (0.11) (0.02) — Multiemployer plan withdrawal charge (m) 0.04 — — Brazilian non-income tax credits (n) (0.08) — — Gain on inventory and other adjustments (o) (0.14) — — Other charges (credits) (p) 0.08 0.07 (0.09) Impact of certain discrete tax items (r) (0.06) 0.17 0.54 Non-GAAP earnings per diluted share (v) $ 7.02 $ 7.44 $ 7.65 (a) Acquisition-related step-up inventory amortization represents the amortization of the fair value step-up in Dipsol’s inventories as a result of the acquisition which is recorded within Cost of goods sold in the Company’s Consolidated Statements of Operations.
Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA.
Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA.
Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, impairment charges, and restructuring charges, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense, net and Other income (expense), net.
Operating expenses not directly attributable to the net sales of each respective segment, such as certain corporate and administrative costs, impairment charges, and restructuring charges, are not included in segment operating earnings. Other items not specifically identified with the Company’s reportable segments include Interest expense and Other (expense) income, net.
Segment operating earnings in EMEA were $99.4 million, a decrease of $5.4 million or 5% compared to 2023 primarily driven by the decrease in net sales, partially offset by an improvement in segment operating margins driven by the Company’s margin improvement initiatives. Asia/Pacific Asia/Pacific represented approximately 23% of the Company’s consolidated net sales in 2024.
Segment operating earnings in EMEA were $99.4 million in 2024, a decrease of $5.4 million or 5% compared to 2023 primarily driven by the decrease in net sales, partially offset by an improvement in segment operating margins driven by the Company’s margin improvement initiatives. Asia/Pacific Asia/Pacific represented approximately 23% of the Company’s consolidated net sales in 2024.
The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis. 30 Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures.
The Company believes these non-GAAP measures provide transparent and useful information and are widely used by analysts, investors, and competitors in our industry as well as by management in assessing the operating performance of the Company on a consistent basis. Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures.
Segment operating earnings in the Americas were $244.0 million, a decrease of $22.1 million or 8% compared to 2023 primarily driven by the decrease in net sales, partially offset by an improvement in segment operating margins driven by the Company’s margin improvement initiatives. 37 EMEA EMEA represented approximately 29% of the Company’s consolidated net sales in 2024.
Segment operating earnings in the Americas were $244.0 million in 2024, a decrease of $22.1 million or 8% compared to 2023 primarily driven by the decrease in net sales, partially offset by an improvement in segment operating margins driven by the Company’s margin improvement initiatives. EMEA EMEA represented approximately 29% of the Company’s consolidated net sales in 2024.
The segment’s net sales were $536.4 million, a decrease of $34.9 million or 6% compared to 2023. This was driven by a decline in sales volumes of 5% and a decline in selling price and product mix of 4%, partially offset by a contribution of sales from the acquisition of IKV of 3%.
The segment’s net sales were $536.4 million in 2024, a decrease of $34.9 million or 6% compared to 2023. This was driven by a decline in sales volumes of 5% and a decline in selling price and product mix of 4%, partially offset by a contribution of sales from the acquisition of IKV of 3%.
The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that management believes are not indicative of future operating performance or not considered core to the Company’s operations.
The Company also presents adjusted EBITDA, which is calculated as EBITDA plus or minus certain items that management believes are not indicative of future operating performance or core to the Company’s operations.
(q) Taxes on income before equity in net income of associated companies – adjusted presents the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of net income attributable to Quaker Chemical Corporation to adjusted EBITDA and was determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility.
(t) Taxes on income before equity in net income of associated companies – adjusted presents the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of net income attributable to Quaker Chemical Corporation to adjusted EBITDA and was determined utilizing the applicable rates in the taxing jurisdictions in which these adjustments occurred, subject to deductibility.
While the Company has considered future taxable income and assesses the need for a valuation allowance, in the event Quaker Houghton were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to the deferred tax asset would increase income in the period such determination was made.
While the Company has considered future taxable income and assesses the need for a valuation allowance, in the event the Company were to determine that it would be able to realize its deferred tax assets in the future in excess of its net recorded amount, an adjustment to the deferred tax asset would increase income in the period such determination was made.
The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including the actual and projected demand for our products, specialty chemical industry conditions, competitive factors, and the condition of financial markets, among others. 29 The following table summarizes the Company’s contractual obligations as of December 31, 2024, and the effect such obligations are expected to have on its liquidity and cash flows in future periods.
The timing and amount of potential capital requirements cannot be determined at this time and will depend on a number of factors, including the actual and projected demand for our products, specialty chemical industry conditions, competitive factors, and the condition of financial markets, among others. 31 The following table summarizes the Company’s contractual obligations as of December 31, 2025, and the effect such obligations are expected to have on its liquidity and cash flows in future periods.
Cost of goods sold (“COGS”) were $1,153.7 million in 2024 compared to $1,247.7 million in 2023. The decrease of COGS of $94.0 million, or 8%, reflects lower spend on the decline in current year sales volumes and a modest decline in the Company’s global raw material costs.
Cost of goods sold (“COGS”) were $1,153.7 million in 2024 compared to $1,247.7 million in 2023. The decrease of COGS of $94.0 million, or 8%, reflects lower spend on the decline in 2024 sales volumes and a modest decline in the Company’s global raw material costs.
However, should the entire liability be paid, the amount of the payment may be reduced by up to $5.6 million as a result of offsetting benefits in other tax jurisdictions. See Note 10, Income Taxes , to the Consolidated Financial Statements for more information.
However, should the entire liability be paid, the amount of the payment may be reduced by up to $7.5 million as a result of offsetting benefits in other tax jurisdictions. See Note 10, Income Taxes , to the Consolidated Financial Statements for more information.
The decrease of $4.3 million was primarily due to lower current year income from the Company’s 50% equity interest in a joint venture in Korea offset by higher current year income from the Company’s equity interest in Primex. Net income attributable to noncontrolling interest was approximately $0.1 million for both 2024 and 2023.
The decrease of $4.3 million was primarily due to lower 2024 income from the Company’s 50% equity interest in a joint venture in Korea offset by higher 2024 income from the Company’s equity interest in Primex. Net income attributable to noncontrolling interest was approximately $0.1 million for both 2024 and 2023.
Interest expense, net, of $41.0 million decreased $9.7 million in 2024 compared to $50.7 million in 2023, primarily as a result of lower outstanding borrowings and decreases in interest rates. 35 The Company’s effective tax rates for 2024 and 2023 were 31.8% and 36.3%, respectively.
Interest expense of $41.0 million decreased $9.7 million in 2024 compared to $50.7 million in 2023, primarily as a result of lower outstanding borrowings and decreases in interest rates. The Company’s effective tax rates for 2024 and 2023 were 31.8% and 36.3%, respectively.
Interest obligations on the Company’s long-term debt and capital leases assume the current debt levels will be outstanding for the entire respective period and apply the interest rates in effect as of December 31, 2024.
Interest obligations on the Company’s long-term debt and capital leases assume the current debt levels will be outstanding for the entire respective period and apply the interest rates in effect as of December 31, 2025.
Financial covenants contained in the Credit Facility include a consolidated interest coverage ratio test and a consolidated net leverage ratio test. As of December 31, 2024, the Company was in compliance with all of the Credit Facility covenants.
Financial covenants contained in the Credit Facility include a consolidated interest coverage ratio test and a consolidated net leverage ratio test. As of December 31, 2025, the Company was in compliance with all of the Credit Facility covenants.
Pension and postretirement plan contributions beyond 2025 are not determinable since the amount of any contribution is heavily dependent on the future economic environment and investment returns on pension trust assets. The timing of payments related to other long-term liabilities which consists primarily of deferred compensation agreements and environmental reserves, also cannot be readily determined due to their uncertainty.
Pension and postretirement plan contributions beyond 2026 are not determinable since the amount of any contribution is heavily dependent on the future economic environment and investment returns on pension trust assets. The timing of payments related to other long-term liabilities which consist primarily of deferred compensation agreements and environmental reserves, also cannot be readily determined due to their uncertainty.
The Company’s current year effective tax rate was primarily impacted by the mix of pre-tax earnings, certain one-time charges related to an intercompany intangible asset transfer, provision to return and other adjustments, and withholding taxes, offset by changes in uncertain tax positions.
The Company’s 2024 effective tax rate was primarily impacted by the mix of pre-tax earnings, certain one-time charges related to an intercompany intangible asset transfer, provision to return and other adjustments, and withholding taxes, offset by changes in uncertain tax positions.
(h) Equity income (loss) in a captive insurance company represents the after-tax income attributable to the Company’s equity interest in Primex, Ltd. (“Primex”), a captive insurance company. The Company holds a 32% investment in and has significant influence over Primex, and therefore accounts for this investment under the equity method of accounting.
(q) Equity income in a captive insurance company represents the after-tax income attributable to the Company’s equity interest in Primex, Ltd. (“Primex”), a captive insurance company. The Company holds a 32% investment in and has significant influence over Primex, and therefore accounts for this investment under the equity method of accounting.
The Company’s current year improvement in gross margin was primarily driven by our value-based pricing model and modest improvements in raw material costs.
The Company’s improvement in gross margin was primarily driven by our value-based pricing model and modest improvements in raw material costs.
The Company may experience continued volatility in its effective tax rates due to several factors, including the timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, the unpredictability of the timing and amount of certain incentives in various tax jurisdictions, and the timing and amount of certain share-based compensation-related tax benefits, among other factors.
The Company may experience continued volatility in its effective tax rates due to several factors, including the timing of tax audits and the expiration of applicable statutes of limitations as they relate to uncertain tax positions, the unpredictability of the timing and amount of certain incentives in various tax jurisdictions, the tax impacts of acquisition and related integration activities, and the timing and amount of certain share-based compensation-related tax benefits, among other factors.
Dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility (the “ Original Credit Facility”).
Dollar swing line lender and letter of credit issuer, Bank of America Europe Designated Active Company, as Euro Swing Line Lender, certain guarantors and other lenders entered into an amendment to its primary credit facility (the “Original Credit Facility”).
The decrease in selling price and product mix was attributable to the impact of our index-based customer contracts and the mix of products and services.
The decrease in selling price and product mix was primarily attributable to the impact of the mix of products, services and geographies and the impact of our index-based customer contracts.
Additionally, the Company had higher non-income tax refunds of $3.7 million in the current year compared to non-income tax refunds of $1.3 million in the prior year.
Additionally, the Company had higher non-income tax refunds of $3.7 million in 2024 compared to non-income tax refunds of $1.3 million in the prior year.
The segment’s net sales were $421.1 million, an increase of 4% or approximately $16.2 million compared to 2023.
The segment’s net sales were $421.1 million in 2024, an increase of 4% or approximately $16.2 million compared to 2023.
The Company’s 2023 effective tax rate was primarily impacted by changes to the valuation allowance for and the usage of certain foreign tax credits, withholding taxes and deferred taxes on unremitted earnings, and the mix of pre-tax earnings.
The Company’s 2023 effective tax rate was primarily impacted by changes to the valuation allowance for and the usage of certain FTCs, withholding taxes and deferred taxes on unremitted earnings, and the mix of pre-tax earnings.
In addition, the foreign tax credit valuation allowance, or absence thereof, is based on a number of variables, including forecasted earnings, which may vary. Equity in net income of associated companies was $11.0 million in 2024 compared to $15.3 million in 2023.
In addition, the FTC valuation allowance, or absence thereof, is based on a number of variables, including forecasted earnings, which may vary. Equity in net income of associated companies was $11.0 million in 2024 compared to $15.3 million in 2023.
(p) Depreciation and amortization includes $1.0 million for each of the years ended December 31, 2024, 2023 and 2022, respectively, of amortization expense recorded within equity in net income of associated companies in the Company’s Consolidated Statements of Operations, which is attributable to amortization of the fair value purchase accounting step-up in connection with acquisition of the Company’s 50% equity interest in Korea Houghton Corporation.
(s) Depreciation and amortization includes $0.9 million, $1.0 million and $1.0 million for the years ended December 31, 2025, 2024 and 2023, respectively, of amortization expense recorded within equity in net income of associated companies in the Company’s Consolidated Statements of Operations, which is attributable to amortization of the fair value purchase accounting step-up in connection with acquisition of the Company’s 50% equity interest in Korea Houghton Corporation.
We generally reserve for large and/or financially distressed customers on a specific review basis, while a general reserve is maintained for other customers based on historical experience. The Company’s consolidated allowance for credit losses was $13.6 million and $13.3 million as of December 31, 2024 and 2023, respectively.
We generally reserve for large and/or financially distressed customers on a specific review basis, while a general reserve is maintained for other customers based on historical experience. The Company’s consolidated allowance for credit losses was $14.9 million and $13.6 million as of December 31, 2025 and 2024, respectively.
However, the Company may also be subject to other taxes, such as withholding taxes and dividend distribution taxes, if certain undistributed earnings are ultimately remitted to the U.S.
The Company may also be subject to other taxes, such as withholding taxes and dividend distribution taxes, if these undistributed earnings are ultimately remitted to the U.S.
The Company made cash payments related to the settlement of restructuring liabilities under the program of $7.6 million and $9.8 million during the years ended December 31, 2024 and 2023, respectively. The Company expects total one-time cash costs of this program to be approximately 1 to 1.5 times annualized savings.
The Company made cash payments related to the settlement of restructuring liabilities under the program of $26.6 million and $7.6 million during the years ended December 31, 2025 and 2024, respectively. The Company expects total one-time cash costs of this program to be approximately 1 to 1.5 times annualized savings.
As of December 31, 2024, the Company has a deferred tax liability of $8.4 million, which primarily represents the estimate of the non-U.S. taxes the Company will incur to remit certain previously taxed earnings to the U.S.
As of December 31, 2025, the Company has a deferred tax liability of $8.5 million, which primarily represents the estimate of the non-U.S. taxes the Company will incur to remit certain previously taxed earnings to the U.S.
(s) The Company calculates non-GAAP earnings per diluted share as non-GAAP net income attributable to the Company per weighted average diluted shares outstanding using the “two-class share method” to calculate such in each given period. Off-Balance Sheet Arrangements The Company had approximately $6 million of bank letters of credit and guarantees as of December 31, 2024.
(v) The Company calculates non-GAAP earnings per diluted share as non-GAAP net income attributable to the Company per weighted average diluted shares outstanding using the “two-class share method” to calculate such in each given period. Off-Balance Sheet Arrangements The Company had approximately $7 million of bank letters of credit and guarantees as of December 31, 2025.
Refer to the description of the Company’s primary Credit Facility in Note 19, Debt , to the Consolidated Financial Statements for more information about the covenants and events of default. The weighted average variable interest rate incurred on the outstanding borrowings under the Credit Facility during the twelve months ended December 31, 2024 was approximately 6.1%.
Refer to the description of the Company’s primary Credit Facility in Note 19, Debt , to the Consolidated Financial Statements for more information about the covenants and events of default. The weighted average variable interest rate incurred on the outstanding borrowings under the Credit Facility during the twelve months ended December 31, 2025 was approximately 5.2%.
The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain assets and/or liabilities denominated in certain foreign currencies.
The Company uses foreign exchange forward contracts to economically hedge the impact of the variability in exchange rates on certain foreign currency-denominated assets and liabilities.
As of December 31, 2024, the interest rate on the outstanding borrowings under the Credit Facility was approximately 5.2%. As part of the Credit Facility, the Company is required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio.
As of December 31, 2025, the interest rate on the outstanding borrowings under the Credit Facility was approximately 4.7%. As part of the Credit Facility, the Company is required to pay an annual commitment fee ranging from 0.150% to 0.275% related to unutilized commitments under the Revolver, depending on the Company’s consolidated net leverage ratio.
Term Loan and Revolver in connection to the amended Credit Facility during the second quarter of 2022. Capitalized costs attributed to the Euro Term Loan and U.S. Term Loan are recorded as a direct offset to Long-term debt on the Consolidated Balance Sheets. Capitalized costs attributed to the Revolver are recorded within Other assets on the Consolidated Balance Sheets.
Term Loan and Revolver during the second quarter of 2022. Capitalized costs attributed to the Euro Term Loan and U.S. Term Loan are recorded as a direct offset to Long-term debt on the Consolidated Balance Sheets. Capitalized costs attributed to the Revolver are recorded within Other assets on the Consolidated Balance Sheets.
See Note 7, Restructuring and Related Activities , to the Consolidated Financial Statements for more information. As of December 31, 2024, the Company’s gross liability for uncertain tax positions, including interest and penalties, was $17.3 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability.
See Note 7, Restructuring and Related Activities , to the Consolidated Financial Statements for more information. 30 As of December 31, 2025, the Company’s gross liability for uncertain tax positions, including interest and penalties, was $14.2 million. The Company cannot determine a reliable estimate of the timing of cash flows by period related to its uncertain tax position liability.
It is the Company’s current intention to reinvest its future undistributed earnings of non-U.S. subsidiaries to support working capital needs and certain other growth initiatives outside of the U.S. The amount of such undistributed earnings at December 31, 2024 was approximately $359.8 million.
It is the Company’s current intention to reinvest its future undistributed earnings of non-U.S. subsidiaries to support working capital needs and certain other growth initiatives outside of the U.S. The amount of such undistributed earnings at December 31, 2025 was approximately $429.2 million.
Excluding the impact of all non-core items in each year, described in the Non-GAAP Measures section of this Item, above, the Company estimates that the 2023 and 2022 effective tax rates would have been approximately 28% and 27%, respectively.
Excluding the impact of all non-core items in each year, described in the Non-GAAP Measures section of this Item above, the Company estimates that the 2025 and 2024 effective tax rates would have been approximately 28% and 29%, respectively.
The unfavorable foreign exchange impact was primarily due to the strengthening of the U.S. dollar against the Mexican peso and Brazilian real.
The unfavorable foreign exchange impact was primarily due to the strengthening of the U.S. dollar against the Brazilian real and Mexican peso during 2025 compared to 2024.
The Company recognized $6.5 million, $7.6 million and $3.2 million of restructuring and related charges for the years ended December 31, 2024, 2023 and 2022, respectively, as a result of these programs and other facility closure actions.
The Company recognized $35.1 million, $6.5 million and $7.6 million of restructuring and related charges for the years ended December 31, 2025, 2024 and 2023, respectively, as a result of these programs and other facility closure actions.
The Company recorded expense to increase its provision for credit losses by $2.1 million, $1.3 million and $4.3 million for the years ended December 31, 2024, 2023 and 2022, respectively.
The Company recorded expense to increase its provision for credit losses by $0.7 million, $2.1 million and $1.3 million for the years ended December 31, 2025, 2024 and 2023, respectively.
The bank letters of credit and guarantees are not significant to the Company’s liquidity or capital resources. 34 Operations Consolidated Operations Review – Comparison of 2024 with 2023 The following table summarizes the sales variances by reportable segment and consolidated operations from the prior year: Sales volumes Selling price & product mix Foreign currency Acquisition & other Total Americas (5) % (4) % (1) % — % (10) % EMEA (5) % (4) % — % 3 % (6) % Asia/Pacific 7 % (3) % (2) % 2 % 4 % Consolidated (2) % (4) % (1) % 1 % (6) % Net sales of $1,839.7 million in 2024 decreased 6% compared to $1,953.3 million in 2023, primarily due to a decrease in selling price and product mix of approximately 4%, a decrease in sales volumes of approximately 2%, and unfavorable impacts from foreign currency translation of approximately 1%, partially offset by an increase in sales from acquisitions of approximately 1%.
Consolidated Operations Review – Comparison of 2024 with 2023 The following table summarizes sales variances by segment and consolidated operations from the prior year: Sales volumes Selling price & product mix Foreign currency Acquisition & other Total Americas (5) % (4) % (1) % — % (10) % EMEA (5) % (4) % — % 3 % (6) % Asia/Pacific 7 % (3) % (2) % 2 % 4 % Consolidated (2) % (4) % (1) % 1 % (6) % Net sales of $1,839.7 million in 2024 decreased 6% compared to $1,953.3 million in 2023, primarily due to a decrease in selling price and product mix of approximately 4%, a decrease in sales volumes of approximately 2%, and unfavorable impacts from foreign currency translation of approximately 1%, partially offset by an increase in sales from acquisitions of approximately 1%.
(c) Strategic planning (credits) expenses include certain consultant and advisory expenses for the Company's long-term strategic planning, as well as process optimization and the next phase of the Company's long-term integration to further optimize its footprint, processes and other functions. (d) Executive transition costs represent the costs related to the Company’s transition of executive officers.
(d) Strategic planning expenses (credits) include certain consultant and advisory expenses for the Company's long-term strategic planning, as well as process optimization and the next phase of the Company's long-term integration to further optimize its footprint, processes and other functions.
Operating income in 2024 was $194.7 million compared to $214.5 million in 2023. Excluding non-core items that are not indicative of future operating performance, as detailed above, the Company’s current year non-GAAP operating income was $213.7 million compared to $227.8 million in the prior year.
Operating income in 2024 was $194.7 million compared to $214.5 million in 2023. Excluding non-core items that are not indicative of future operating performance, as detailed above, the Company’s 2024 non-GAAP operating income was $213.7 million compared to $227.8 million in the prior year. The decrease in non-GAAP operating income was primarily due to lower gross profit, as described above.
(e) Customer insolvency costs represent charges associated with specific reserves for trade accounts receivable within the Company’s EMEA and America’s reportable segments related to two specific customers that filed for bankruptcy protection.
(f) Executive transition costs represent the costs related to the Company’s transition of executive officers. (g) Customer insolvency costs represent charges associated with specific reserves for trade accounts receivable within the Company’s EMEA and America’s reportable segments related to two specific customers that filed for bankruptcy protection.
The decline in sales volumes was primarily driven by softer market conditions broadly across the portfolio, partially offset by new business wins. The decline in selling price and product mix was primarily attributable to the impact of our index-based customer contacts and the mix of products and services.
The decrease in selling price and product mix was primarily attributable to the impact of the mix of products, services and geographies and the impact of our index-based customer contracts. The decline in sales volumes was primarily driven by softer market conditions, partially offset by continued new business wins.
The unfavorable foreign exchange impact was primarily due to the strengthening of the U.S. dollar against the Chinese renminbi.
The unfavorable foreign currency translation was primarily due to the strengthening of the U.S. dollar against the Chinese renminbi.
(r) The Company calculates adjusted EBITDA margin and non-GAAP operating margin as the percentage of adjusted EBITDA and non-GAAP operating income, respectively, to consolidated net sales.
(u) The Company calculates adjusted EBITDA margin, non-GAAP operating margin, and non-GAAP gross margin as the percentage of adjusted EBITDA, non-GAAP operating income, and non-GAAP gross profit to consolidated net sales.
See Notes 1, 4, 5, and 15 of Notes to Consolidated Financial Statements in Item 8 of this Report. Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related product costs and other operating expenses.
See Notes 1, 4, 5, and 15 to the Consolidated Financial Statements for more information. Segment operating earnings for each of the Company’s reportable segments are comprised of the segment’s net sales less directly related product costs and other segment items.
The Company also records valuation allowances when necessary to reduce its deferred tax assets to the amount that is more likely than not to be realized.
The Company also records valuation allowances on a quarterly basis to reduce its deferred tax assets to the amount that is more likely than not to be realized.
Excluding non-recurring and non-core items, the Company’s current year non-GAAP net income and non-GAAP earnings per diluted share were $133.5 million and $7.44, respectively, compared to $137.6 million and $7.65, respectively, in 2023.
Excluding non-recurring and non-core items, the Company’s current year non-GAAP net income and non-GAAP earnings per diluted share were $123.2 million and $7.02, respectively, compared to $133.5 million and $7.44, respectively, in 2024.
However, actual results may differ materially from these estimates under different assumptions or conditions. 25 Quaker Houghton believes the following critical accounting policies describe the more significant judgments and estimates used in the preparation of its consolidated financial statements: Accounts receivable and inventory exposures: The Company establishes allowances for credit losses for estimated losses resulting from the inability of its customers to make required payments.
Quaker Houghton believes the following critical accounting policies describe the more significant judgments and estimates used in the preparation of its consolidated financial statements: Accounts receivable and inventory exposures: The Company establishes allowances for credit losses for estimated losses resulting from the inability of its customers to make required payments.
Likewise, should the Company determine that it would not be able to realize all or part of its net deferred tax assets in the future, an adjustment to the deferred tax asset would be charged to income in the period such determination was made. Both determinations could have a material impact on the Company’s financial statements.
Likewise, should the Company determine that it would not be able to realize all or part of its net deferred tax assets in the future, an adjustment to the deferred tax asset would be charged to income in the period such determination was made.
Critical Accounting Policies and Estimates Quaker Houghton’s discussion and analysis of its financial condition and results of operations are based on its consolidated financial statements which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).
The Company is continuing to evaluate the potential impacts of the provisions effective in 2026 and 2027. 26 Critical Accounting Policies and Estimates Quaker Houghton’s discussion and analysis of its financial condition and results of operations are based on its consolidated financial statements which have been prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”).
Any tax liability which might result from ultimate remittance of these earnings is expected to be substantially offset by foreign tax credits (subject to certain limitations), however, certain withholding taxes could apply. It is currently impractical to estimate any such incremental tax expense.
Any tax liability which might result from ultimate remittance of these earnings is expected to be substantially offset by foreign tax credits (“FTCs”) (subject to certain limitations), however, certain withholding taxes could apply. It is currently impractical to estimate any such incremental tax expense. See Note 10, Income Taxes , to the Consolidated Financial Statements for more information.
The Company had unused capacity under the Revolver of approximately $448.7 million, which is net of bank letters of credit of approximately $2.4 million, as of December 31, 2024.
The Company had unused capacity under the Revolver of approximately $268.5 million, which is net of bank letters of credit of approximately $2.5 million, as of December 31, 2025.
Operating earnings for the Americas and EMEA segments decreased compared to the prior year, primarily driven by a decrease in net sales, partially offset by an increase in segment operating margins. Asia/Pacific segment operating earnings increased compared to the prior year, primarily driven by an increase in net sales, partially offset by a decrease in segment operating margins.
The decrease in operating earnings for the EMEA segment compared to the prior year was primarily driven by lower segment operating margins, partially offset by an increase in net sales. The decrease in operating earnings for the America segment compared to the prior year was primarily driven by a decrease in net sales and a decrease in segment operating margins.
Reportable Segments Review - Comparison of 2024 with 2023 The Company’s reportable segments reflect the structure of the Company’s internal organization, the method by which the Company’s resources are allocated and the manner by which the Chief Operating Decision Maker of the Company assesses its performance.
Reportable Segments Review - Comparison of 2025 with 2024 The Company’s reportable segments reflect the structure of the Company’s internal organization, the method by which the Company’s resources are allocated and the manner by which the Chief Operating Decision Maker of the Company assesses its performance. The Company has three reportable segments: (i) Americas; (ii) EMEA; and (iii) Asia/Pacific.
Independent actuaries, in accordance with U.S. GAAP, perform the required valuations to determine benefit expense and, if necessary, non-cash charges to equity for additional minimum pension liabilities.
Pension and Postretirement benefits: The Company provides certain defined benefit pension and other postretirement benefits to current employees, former employees and retirees. Independent actuaries, in accordance with U.S. GAAP, perform the required valuations to determine benefit expense and, if necessary, non-cash charges to equity for additional minimum pension liabilities.
During 2022, the Company’s management initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. The Company has achieved its initial full run-rate cost savings goal from the global cost and optimization program of approximately $20 million.
During 2022, the Company initiated a global cost and optimization program to improve its cost structure and drive a more profitable and productive organization. The Company has achieved its annualized cost savings goal from this program of at least $20 million.
When necessary, the Company consults with external advisors to help determine fair value. For non-observable market values, the Company may determine fair value using acceptable valuation principles, including the excess earnings, relief from royalty, lost profit or cost methods. The Company amortizes definite-lived intangible assets on a straight-line basis over their useful lives.
When necessary, the Company consults with external advisors to help determine fair value. For non-observable market values, the Company may determine fair value using acceptable valuation principles, including the excess earnings, relief from royalty, lost profit or cost methods.
In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that management believes are not indicative of future operating performance or considers core to the Company’s operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively.
The Company presents non-GAAP operating income, which is calculated as operating income plus or minus certain items that management believes are not indicative of future operating performance or core to the Company’s operations.
Initial investigations identified soil and ground water contamination in select areas of the site. The site has conducted a multi-year soil and groundwater investigation and corresponding risk assessments based on the result of the investigations.
The site has conducted a multi-year soil and groundwater investigation and corresponding risk assessments based on the result of the investigations.
The Company’s total net debt as of December 31, 2024 was $519.4 million, which consists of total borrowings of $708.3 million less cash and cash equivalents of $188.9 million. The Credit Facility contains affirmative and negative covenants, financial covenants and events of default.
The Company’s total net debt as of December 31, 2025 was $691.4 million, which consists of total borrowings of $871.2 million less cash and cash equivalents of $179.8 million. The Credit Facility contains affirmative and negative covenants, financial covenants and events of default.
ACP began to perform such testing program work in 2022, and an additional round of testing is expected to commence in 2025. As of December 31, 2024, ACP believes it is close to meeting the conditions for closure of the remaining groundwater treatment system but continues to operate this system while in discussions with the relevant authorities.
ACP has performed such testing program work with an additional round of testing done in 2025. It is expected that additional testing may occur in 2026. As of December 31, 2025, ACP believes it has met the conditions for closure of the remaining groundwater treatment system but continues to operate this system while in discussions with the relevant authorities.
Additional details of each segment’s operating performance are further discussed in the Company’s reportable segments review, in the Operations section of this Item 7, below. Net cash flows provided by operating activities were $204.6 million in 2024 compared to $279.0 million in 2023.
Additional details of segment operating performance are provided in the Reportable Segments Review in the Operations section of this Item below. Net cash flows provided by operating activities were $136.5 million in 2025 compared to $204.6 million in 2024.
The Company’s other debt obligations are primarily industrial development bonds, bank lines of credit and municipality-related loans, which totaled $11.8 million as of December 31, 2024. Total unused capacity under these arrangements as of December 31, 2024 was approximately $32.9 million.
As of December 31, 2025, the Company had Credit Facility borrowings outstanding of $859.7 million. The Company’s other debt obligations are primarily industrial development bonds, bank lines of credit and municipality-related loans, which totaled $11.5 million as of December 31, 2025. Total unused capacity under these arrangements as of December 31, 2025 was approximately $57.4 million.
Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge, and customized services. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the U.S.
Our high-performing, innovative and sustainable solutions are backed by best-in-class technology, deep process knowledge, and customized services. Quaker Houghton is headquartered in Conshohocken, Pennsylvania, located near Philadelphia in the U.S. Net sales of $1,888.6 million in 2025 increased 3% compared to $1,839.7 million in 2024.
In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income, and non-GAAP earnings per share, as discussed and reconciled below to the most comparable GAAP measures, may not be comparable to similarly named measures reported by other companies.
In addition, our definitions of EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP gross profit, non-GAAP gross margin, taxes on income before equity in net income of associated companies – adjusted, non-GAAP net income, and non-GAAP earnings per share, as discussed and reconciled below to the most comparable GAAP measures, may not be comparable to similarly named measures reported by other companies. 32 The Company presents EBITDA, which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, and taxes on income before equity in net income of associated companies.
The decrease in net operating cash flows was primarily driven by a reduction in cash inflow from working capital in the current year. The key drivers of the Company’s operating cash flow and overall liquidity are further discussed in the Company’s Liquidity and Capital Resources section of this Item 7, below.
The decrease in net operating cash flows was primarily driven by lower operating performance, higher cash outflows from restructuring activities and higher outflows from working capital in 2025 compared to 2024. The key drivers of the Company’s operating cash flow and working capital are further discussed in the Company’s Liquidity and Capital Resources section of this Item 7, below.
Goodwill and intangible assets that have indefinite lives are not amortized and are required to be assessed at least annually for impairment. The Company completes its annual goodwill and indefinite-lived intangible asset impairment test during the fourth quarter of each year, or more frequently if triggering events indicate a possible impairment.
The Company completes its annual goodwill and indefinite-lived intangible asset impairment test during the fourth quarter of each year, or more frequently if triggering events indicate a possible impairment.
Pursuant to the Tax Cuts and Jobs Act (“U.S. Tax Reform”), the Company recorded a $15.5 million transition tax liability for U.S. income taxes on the undistributed earnings of non-U.S. subsidiaries. As of December 31, 2024, $11.6 million in installments have been paid with the remaining $3.9 million to be paid in 2025.
Both determinations could have a material impact on the Company’s financial statements. 27 Pursuant to the Tax Cuts and Jobs Act (“U.S. Tax Reform”), the Company recorded a $15.5 million transition tax liability for U.S. income taxes on the undistributed earnings of non-U.S. subsidiaries. As of December 31, 2025, the $15.5 million transition liability has been fully paid.
The decrease in non-GAAP operating income was primarily due to lower gross profit, as described above. The Company had Other income, net of $1.4 million in 2024 compared to Other expense, net of $10.7 million in 2023 due to lower foreign exchange losses of $1.8 million in the current year compared to losses of $14.8 million in the prior year.
See the Non-GAAP Measures section of this Item above for additional details. 38 The Company had Other income, net of $1.4 million in 2024 compared to Other expense, net of $10.7 million in 2023 due to lower foreign exchange losses of $1.8 million in 2024 compared to losses of $14.8 million in the prior year.
See Note 25, Commitments and Contingencies , to the Consolidated Financial Statements for additional details. General See Item 7A of this Report, below, for further discussion of certain quantitative and qualitative disclosures about market risk.
Notwithstanding the foregoing, the Company cannot be certain that future liabilities in the form of remediation expenses and damages will not exceed amounts reserved. See Note 25, Commitments and Contingencies , to the Consolidated Financial Statements for additional details. General See Item 7A of this Report, below, for further discussion of certain quantitative and qualitative disclosures about market risk.
Tribologie IKVT and its subsidiaries (“IKV”), a $3.0 million increase in capital expenditures, and a reduction of proceeds from asset dispositions of $6.5 million. See Note 2, Business Combinations , to the Consolidated Financial Statements for further information about business acquisitions. Net cash flows used in financing activities were $122.7 million in 2024 compared to $238.6 million in 2023.
Tribologie IKVT and its subsidiaries (“IKV”) and the Sutai Group (“Sutai”). See Note 2, Business Combinations , to the Consolidated Financial Statements for further information about business acquisitions. Net cash flows provided by financing activities were $61.8 million in 2025 compared to net cash flows used in financing activities of $122.7 million in 2024.
Reportable Segments Review – Comparison of 2023 with 2022 Americas Americas represented approximately 50% of the Company’s consolidated net sales in 2023. The segment’s net sales were $977.1 million, an increase of $30.6 million or 3% compared to 2022.
Reportable Segments Review – Comparison of 2024 with 2023 Americas Americas represented approximately 48% of the Company’s consolidated net sales in 2024. The segment’s net sales were $882.1 million in 2024, a decrease of $95.0 million or 10% compared to 2023.
As of December 31, 2024 and 2023, the Company had $1.1 million and $1.5 million, respectively, of debt issuance costs recorded as a reduction of Long-term debt and $2.4 million and $3.3 million, respectively, of debt issuance costs recorded within Other assets.
These capitalized costs are amortized into Interest expense over the five year term of the Credit Facility. As of December 31, 2025 and 2024, the Company had $0.7 million and $1.1 million, respectively, of debt issuance costs recorded as a reduction of Long-term debt and $1.4 million and $2.4 million, respectively, of debt issuance costs recorded within Other assets.